Angiogenic peptide
US9925398B2 · kind B2 · utility
0Cited by
4References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 23, 2009 |
| Grant date | Mar 27, 2018 |
| Priority date | — |
| Expiry date | Jan 24, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application discloses angiogenic peptides that cause intracellular calcium release in target cells and thereby induce proliferation, migration, and capillary-like tube formation in primary cultured endothelial cells. The angiogenic peptides can be used for preventing and/or treating angiognesis-related conditions, especially wound healing, treating foot and leg ulcers in a subject, etc. In addition, the angiogenic peptides can be used for cosmetics a constituent of cosmetics for aged skin, for examples, anti-wrinkle and skin whitening.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.